Benzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: A randomized clinical trial

Acta Ophthalmologica

Volumn 90, Issue 3, 2012, Pages

  Stevens, Anna M ^a   Kestelyn, Philippe A ^a   De Bacquer, Dirk ^b   Kestelyn, Philippe G ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

anterior chamber inflammation; benzalkonium chloride; glaucoma medication; laser flare meter

Indexed keywords

BENZALKONIUM CHLORIDE; TIMOLOL MALEATE;

ADULT; AGED; ANALYTICAL EQUIPMENT; ANTERIOR EYE CHAMBER INFLAMMATION; ARTICLE; BLOOD EYE BARRIER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; EYE INFLAMMATION; EYE SURGERY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; LASER FLARE METER; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SINGLE BLIND PROCEDURE; TREATMENT DURATION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; AQUEOUS HUMOR; BENZALKONIUM COMPOUNDS; BLOOD-AQUEOUS BARRIER; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PRESERVATIVES, PHARMACEUTICAL; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TIMOLOL; UVEITIS, ANTERIOR;

EID: 84860484141     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2011.02338.x     Document Type: Article

References (29)

1. Baleriola B, Garcia-Feijoo J, Martinez-de-la-Casa J, et al., (2008): Apoptosis in the trabecular meshwork of glaucomatous patients. Mol Vis 14: 1513-1516.
2. Baudouin C, &, de Lunardo C, (1998): Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol 82: 39-42. (Pubitemid 28176961)
3. Baudouin C, Labbé A, Liang H, et al., (2010): Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 19: 312-334.
4. Bigar F, Herbort CP, &, Pittet N, (1991): Tyndallométrie de la chambre antérieure avec le laser Flare-Cell meter Kowa FC-1000. Klin Mbl Augenheilk 198: 396-398.
5. Breusegem C, Spielberg L, Van Ginderdeuren R, et al., (2010): Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial. Ophthalmology 117: 1324-1330.
6. Broadway DC, &, Chang LP, (2001): Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma 10: 237-249. (Pubitemid 32553589)
7. De Jong C, Slotwijk T, Kuppens E, et al., (1994): Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma. Graefes Arch Clin Exp Ophthalmol 232: 221-224. (Pubitemid 24127409)
8. Diestelhorst M, Roters S, &, Krieglstein GK, (1997): The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%. Graefe's Arch Clin Exp Ophthalmol 235: 20-26.
9. Easty DL, Nemeth-Wasmer G, Vounatsos JP, et al., (2006): Comparison of non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucoma patients. Br J Ophthalmol 90: 574-578.
10. El-Harazi SM, Ruiz RS, Feldman RM, et al., (2002): Quantitative assessment of aqueous flare: the effect of age and pupillary dilation. Ophthal Surg Lasers 33: 379-382. (Pubitemid 44714243)
11. Fechtner RD, Godfrey DG, Budenz D, et al., (2010): Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 29: 618-621.
12. Goto Y, Ibaraki N, Miyake K, et al., (2003): Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol. Arch Ophthalmol 121: 835-839. (Pubitemid 36676221)
13. Guillen-Monterrubio OM, Hartikainen J, Taskinen K, et al., (1997): Quantitative determination of aqueous flare and cells in healthy eyes. Acta Ophthalmol Scand 75: 58-62. (Pubitemid 27117186)
14. Hamard P, Blondin C, Debbasch C, et al., (2003): In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells. Graefes Arch Clin Exp Ophthalmol 241: 1037-1043. (Pubitemid 38028900)
15. Jaenen N, Baudouin C, Pouliquen P, et al., (2007): Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 17: 341-349. (Pubitemid 47056287)
16. Leung EW, Medeiros FA, &, Weinreb RN, (2008): Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 17: 350-355.
17. Miyake K, Ota I, Ibaraki N, et al., (2001): Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol 119: 387-394. (Pubitemid 32207261)
18. Miyake K, Ibaraki N, Goto Y, et al., (2003): ESCRS Binkhorst lecture 2002: pseudophakic preservative maculopathy. J Cataract Refract Surg 29: 1800-1810. (Pubitemid 37210621)
19. Onodera T, Gimbel HV, &, Debroff BM, (1993): Aqueous flare and cell number in healthy eyes of Caucasians. Jpn J Ophthalmol 37: 445-451. (Pubitemid 24029367)
20. Oshika T, Araie M, &, Masuda K, (1988): Diurnal variation of aqueous flare in normal human eyes measured with laser flare-cell-meter. Jpn J Ophthalmol 32: 143-150.
21. Oshika T, Kato S, Sawa M, et al., (1989): Aqueous flare intensity and age. Jpn J Ophthalmol 33: 237-242. (Pubitemid 19175116)
22. Pisella PJ, Pouliquen P, &, Baudouin C, (2002): Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 86: 418-423. (Pubitemid 34293291)
23. Rossi GC, Tinelli C, Pasinetti GM, et al., (2009): Dry eye syndrome-related quality of life in glaucoma patients. Eur J Ophthalmol 19: 572-579.
24. Samples JR, Binder PS, &, Nayak S, (1989): The effect of epinephrine and benzalkonium chloride on cultured corneal endothelial and trabecular meshwork cells. Exp Eye Res 49: 1-12. (Pubitemid 19190148)
25. Sawa M, Tsurimaki Y, Tsuru T, et al., (1988): New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol 32: 132-142.
26. Schmier JK, Covert DW, &, Robin AL, (2010): First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008. Curr Med Res Opin 12: 2769-2777.
27. Shah SM, Spalton DJ, &, Smith SE, (1991): Measurement of aqueous cells and flare in normal eyes. Br J Ophthalmol 75: 348-352.
28. Stur M, Grabner G, Huber-Spitzy V, et al., (1986): Effect of timolol on aqueous humor protein concentration in the human eye. Arch Ophthalmol 104: 899-900. (Pubitemid 16114942)
29. Uusitalo H, Chen E, Pfeiffer N, et al., (2010): Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication. Acta Ophthalmol 88: 329-336.